Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU

Core Insights - Biotalys is making significant progress in the regulatory approval of its first protein-based biocontrol product, EVOCA™, in both the United States and Europe [2][3][4] Regulatory Developments - The US Environmental Protection Agency (EPA) is expected to complete the scientific review of EVOCA's dossier by the end of summer 2025, with a regulatory decision projected by September 30, 2025 [3] - In Europe, the Dutch authorities have provided positive evaluations of EVOCA's regulatory dossier, classifying its active ingredient as low risk, which is crucial for its approval process [4][5] Product Information - EVOCA™ is designed to control fungal diseases such as Botrytis and powdery mildew, offering biodegradable solutions for fruit and vegetable growers [6] - The product is based on Biotalys' AGROBODY™ technology platform, which has the potential to develop additional protein-based biocontrol solutions [6][8] Future Outlook - A regulatory decision in the European Union is anticipated in the second half of 2026, contingent upon the provision of additional data during the peer review phase [5] - The approval of EVOCA would represent a major milestone for Biotalys and validate its innovative technology platform [6]